Loading clinical trials...
Loading clinical trials...
To test the effectiveness and tolerability of Lyrica at various dose levels in RLS patients
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
NCT07001891 · Restless Legs Syndrome
NCT06684782 · Restless Legs Syndrome
NCT05908214 · Stroke, Cramp, and more
NCT05321355 · Sleep Disorder, Sleep Disorder Parasomnia, and more
NCT02670161 · Brain Tumors, Epilepsy, and more
Pfizer Investigational Site
Tuscaloosa, Alabama
Pfizer Investigational Site
Little Rock, Arkansas
Pfizer Investigational Site
San Diego, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions